Multi-targeted therapy of cancer by omega-3 fatty acids

Cancer Letters

Volumn 269, Issue 2, 2008, Pages 363-377

  Berquin, Isabelle M ^a   Edwards, Iris J ^a   Chen, Yong Q ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Dietary fat; Omega 3; Omega 6; PUFA

Indexed keywords

LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; COLON CANCER; CYTOTOXICITY; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROSTATE CANCER; RNA TRANSLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

ANIMALIA;

EID: 51349137876     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.044     Document Type: Review

References (127)

1. Simopoulos A.P. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 70 (1999) 560S-569S
2. Simopoulos A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 56 (2002) 365-379
3. C. Wang, M. Chung, E. Balk, B. Kupelnick, D. DeVine, A. Lawrence, A. Lichtenstein, J. Lau, Effects of omega-3 fatty acids on cardiovascular disease, U.S. Department of Health and Human Services Evidence Report/Technology Assessment, 94, 2004. Available from: .
4. C.H. MacLean, A. Issa, P. Khanna, Y. Lim, W.A. Mojica, S.J. Newberry, S.C. Morton, M. Suttorp, W. Tu, L.G. Hilton, et al., Effects of omega-3 fatty acids on cancer, U.S. Department of Health and Human Services Evidence Report/Technology Assessment, 113, 2005. Available from: .
5. P.G. Shekelle, S.C. Morton, C.H. MacLean, R.H. Garland, W. Tu, L.K. Jungvig, W.A. Mojica, J. Pencharz, J. Grossman, P. Khanna, et al., Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis, U.S. Department of Health and Human Services Evidence Report/Technology Assessment, 89, 2004. Available from: .
6. E. Balk, M. Chung, A. Lichtenstein, P. Chew, B. Kupelnick, A. Lawrence, D. DeVine, J. Lau, Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease, U.S. Department of Health and Human Services Evidence Report/Technology Assessment, 93, 2004, Available from: .
7. Tziomalos K., Athyros V.G., and Mikhailidis D.P. Fish oils and vascular disease prevention: an update. Curr. Med. Chem. 14 (2007) 2622-2628
8. Jacobson T.A. Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr. Atheroscler. Rep. 9 (2007) 145-153
9. Carpentier Y.A., Portois L., and Malaisse W.J. n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 83 (2006) 1499S-1504S
10. Barre D.E. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes - a mini-review. J. Oleo. Sci. 56 (2007) 319-325
11. Chen Y.Q., Edwards I.J., Kridel S.J., Thornburg T., and Berquin I.M. Dietary fat-gene interactions in cancer. Cancer Metastasis Rev. 26 (2007) 535-551
12. Sargent J.R. Fish oils and human diet. Br. J. Nutr. 78 Suppl. 1 (1997) S5-S13
13. Larsson S.C., Kumlin M., Ingelman-Sundberg M., and Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79 (2004) 935-945
14. Crawford M.A. The role of dietary fatty acids in biology: their place in the evolution of the human brain. Nutr. Rev. 50 (1992) 3-11
15. Horrobin D.F. Nutritional and medical importance of gamma-linolenic acid. Prog. Lipid Res. 31 (1992) 163-194
16. Qiu X., Hong H., and MacKenzie S.L. Identification of a Delta 4 fatty acid desaturase from Thraustochytrium sp. involved in the biosynthesis of docosahexanoic acid by heterologous expression in Saccharomyces cerevisiae and Brassica juncea. J. Biol. Chem. 276 (2001) 31561-31566
17. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta 1486 (2000) 219-231
18. Williams C.M., and Burdge G. Long-chain n-3 PUFA: plant v. marine sources. Proc. Nutr. Soc. 65 (2006) 42-50
19. Francois C.A., Connor S.L., Bolewicz L.C., and Connor W.E. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am. J. Clin. Nutr. 77 (2003) 226-233
20. Pawlosky R.J., Hibbeln J.R., Novotny J.A., and Salem Jr. N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 42 (2001) 1257-1265
21. Portolesi R., Powell B.C., and Gibson R.A. Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J. Lipid Res. 48 (2007) 1592-1598
22. Marzo I., Alava M.A., Pineiro A., and Naval J. Biosynthesis of docosahexaenoic acid in human cells: evidence that two different delta 6-desaturase activities may exist. Biochim. Biophys. Acta 1301 (1996) 263-272
23. Park Y., and Harris W.S. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J. Lipid Res. 44 (2003) 455-463
24. Sun H., Berquin I.M., Owens R.T., O'Flaherty J.T., and Edwards I.J. Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res. 68 (2008) 2912-2919
25. Arterburn L.M., Hall E.B., and Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83 (2006) 1467S-1476S
26. Terry P.D., Rohan T.E., and Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am. J. Clin. Nutr. 77 (2003) 532-543
27. MacLean C.H., Newberry S.J., Mojica W.A., Khanna P., Issa A.M., Suttorp M.J., Lim Y.W., Traina S.B., Hilton L., Garland R., et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295 (2006) 403-415
28. Chen Y.Q., Berquin I.M., Daniel L.W., Edwards I.J., O'Flaherty J.T., Thomas M.J., Tooze J.A., and Wykle B. Omega-3 fatty acids and cancer risk. JAMA 296 (2006) 282 author reply
29. Kimura Y., Kono S., Toyomura K., Nagano J., Mizoue T., Moore M.A., Mibu R., Tanaka M., Kakeji Y., Maehara Y., et al. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci. 98 (2007) 590-597
30. Theodoratou E., McNeill G., Cetnarskyj R., Farrington S.M., Tenesa A., Barnetson R., Porteous M., Dunlop M., and Campbell H. Dietary fatty acids and colorectal cancer: a case-control study. Am. J. Epidemiol. 166 (2007) 181-195
31. Chavarro J.E., Stampfer M.J., Li H., Campos H., Kurth T., and Ma J. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1364-1370
32. Ritch C.R., Wan R.L., Stephens L.B., Taxy J.B., Huo D., Gong E.M., Zagaja G.P., and Brendler C.B. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J. Urol. 177 (2007) 97-101 discussion 101
33. Kobayashi N., Barnard R.J., Henning S.M., Elashoff D., Reddy S.T., Cohen P., Leung P., Hong-Gonzalez J., Freedland S.J., Said J., et al. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin. Cancer Res. 12 (2006) 4662-4670
34. Berquin I.M., Min Y., Wu R., Wu J., Perry D., Cline J.M., Thomas M.J., Thornburg T., Kulik G., Smith A., et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J. Clin. Invest. 117 (2007) 1866-1875
35. Koh W.P., Yuan J.M., van den Berg D., Lee H.P., and Yu M.C. Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br. J. Cancer 90 (2004) 1760-1764
36. Siezen C.L., van Leeuwen A.I., Kram N.R., Luken M.E., van Kranen H.J., and Kampman E. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. Carcinogenesis 26 (2005) 449-457
37. Hedelin M., Chang E.T., Wiklund F., Bellocco R., Klint A., Adolfsson J., Shahedi K., Xu J., Adami H.O., Gronberg H., et al. Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int. J. Cancer 120 (2007) 398-405
38. Chapkin R.S., McMurray D.N., and Lupton J.R. Colon cancer, fatty acids and anti-inflammatory compounds. Curr. Opin. Gastroenterol. 23 (2007) 48-54
39. Calder P.C., Yaqoob P., Thies F., Wallace F.A., and Miles E.A. Fatty acids and lymphocyte functions. Br. J. Nutr. 87 Suppl. 1 (2002) S31-S48
40. Abou-el-Ela S.H., Prasse K.W., Farrell R.L., Carroll R.W., Wade A.E., and Bunce O.R. Effects of d,l-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res. 49 (1989) 1434-1440
41. Rose D.P., and Connolly J.M. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 50 (1990) 7139-7144
42. Brown M.D., Hart C.A., Gazi E., Bagley S., and Clarke N.W. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br. J. Cancer 94 (2006) 842-853
43. McCarty M.F. Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med. Hypotheses 46 (1996) 107-115
44. Rose D.P., and Connolly J.M. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr. Cancer 37 (2000) 119-127
45. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., and Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196 (2002) 1025-1037
46. Serhan C.N., Arita M., Hong S., and Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39 (2004) 1125-1132
47. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6 (2005) 1191-1197
48. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
49. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
50. Clevers H. At the crossroads of inflammation and cancer. Cell 118 (2004) 671-674
51. Needleman P., Raz A., Minkes M.S., Ferrendelli J.A., and Sprecher H. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc. Natl. Acad. Sci. USA 76 (1979) 944-948
52. Wada M., DeLong C.J., Hong Y.H., Rieke C.J., Song I., Sidhu R.S., Yuan C., Warnock M., Schmaier A.H., Yokoyama C., et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 282 (2007) 22254-22266
53. Reddy B.S., Simi B., Patel N., Aliaga C., and Rao C.V. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Cancer Res. 56 (1996) 2314-2320
54. Singh J., Hamid R., and Reddy B.S. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 57 (1997) 253-258
55. Collett E.D., Davidson L.A., Fan Y.Y., Lupton J.R., and Chapkin R.S. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am. J. Physiol. Cell Physiol. 280 (2001) C1066-C1075
56. Sauer L.A., Blask D.E., and Dauchy R.T. Dietary factors and growth and metabolism in experimental tumors. J. Nutr. Biochem. 18 (2007) 637-649
57. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., and Espat N.J. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2003) L84-L89
58. Liu Y.E., Pu W., Wang J., Kang J.X., and Shi Y.E. Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids. FEBS J. 274 (2007) 3351-3362
59. Edwards I.J., Berquin I.M., Sun H., O'Flaherty J.T., Daniel L.W., Thomas M.J., Rudel L.L., Wykle R.L., and Chen Y.Q. Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin. Clin. Cancer Res. 10 (2004) 8275-8283
60. Berger A., Roberts M.A., and Hoff B. How dietary arachidonic- and docosahexaenoic-acid rich oils differentially affect the murine hepatic transcriptome. Lipids Health Dis. 5 (2006) 10
61. Wassall S.R., Brzustowicz M.R., Shaikh S.R., Cherezov V., Caffrey M., and Stillwell W. Order from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formation. Chem. Phys. Lipids 132 (2004) 79-88
62. Schley P.D., Brindley D.N., and Field C.J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J. Nutr. 137 (2007) 548-553
63. Stoll B.A. N-3 fatty acids and lipid peroxidation in breast cancer inhibition. Br. J. Nutr. 87 (2002) 193-198
64. Fan Y.Y., Spencer T.E., Wang N., Moyer M.P., and Chapkin R.S. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 24 (2003) 1541-1548
65. Zand H., Rhimipour A., Bakhshayesh M., Shafiee M., Nour Mohammadi I., and Salimi S. Involvement of PPAR-gamma and p53 in DHA-induced apoptosis in Reh cells. Mol. Cell. Biochem. 304 (2007) 71-77
66. Chambrier C., Bastard J.P., Rieusset J., Chevillotte E., Bonnefont-Rousselot D., Therond P., Hainque B., Riou J.P., Laville M., and Vidal H. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes. Res. 10 (2002) 518-525
67. Aktas H., and Halperin J.A. Translational regulation of gene expression by omega-3 fatty acids. J. Nutr. 134 (2004) 2487S-2491S
68. Welsch C.W. Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free. Radic. Biol. Med. 18 (1995) 757-773
69. Karmali R.A., Reichel P., Cohen L.A., Terano T., Hirai A., Tamura Y., and Yoshida S. The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res. 7 (1987) 1173-1179
70. Rose D.P., and Cohen L.A. Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis 9 (1988) 603-605
71. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G.V., Li G., Roy-Burman P., Nelson P.S., et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4 (2003) 209-221
72. Gabor H., Hillyard L.A., and Abraham S. Effect of dietary fat on growth kinetics of transplantable mammary adenocarcinoma in BALB/c mice. J. Natl. Cancer Inst. 74 (1985) 1299-1305
73. Rose D.P., and Connolly J.M. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice. J. Natl. Cancer Inst. 85 (1993) 1743-1747
74. Rose D.P., Connolly J.M., Rayburn J., and Coleman M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J. Natl. Cancer Inst. 87 (1995) 587-592
75. Jurkowski J.J., and Cave Jr. W.T. Dietary effects of menhaden oil on the growth and membrane lipid composition of rat mammary tumors. J. Natl. Cancer Inst. 74 (1985) 1145-1150
76. Braden L.M., and Carroll K.K. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 21 (1986) 285-288
77. Reddy B.S., Cohen L.A., McCoy G.D., Hill P., Weisburger J.H., and Wynder E.L. Nutrition and its relationship to cancer. Adv. Cancer Res. 32 (1980) 237-345
78. Jourdan M.L., Maheo K., Barascu A., Goupille C., De Latour M.P., Bougnoux P., and Rio P.G. Increased BRCA1 protein in mammary tumours of rats fed marine omega-3 fatty acids. Oncol. Rep. 17 (2007) 713-719
79. Hardman W.E., Avula C.P., Fernandes G., and Cameron I.L. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin. Cancer Res. 7 (2001) 2041-2049
80. Shao Y., Pardini L., and Pardini R.S. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 30 (1995) 1035-1045
81. Chen J., Hui E., Ip T., and Thompson L.U. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin. Cancer Res. 10 (2004) 7703-7711
82. Pardini R.S. Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem. Biol. Interact. 162 (2006) 89-105
83. Cannizzo Jr. F., and Broitman S.A. Postpromotional effects of dietary marine or safflower oils on large bowel or pulmonary implants of CT-26 in mice. Cancer Res. 49 (1989) 4289-4294
84. Iigo M., Nakagawa T., Ishikawa C., Iwahori Y., Asamoto M., Yazawa K., Araki E., and Tsuda H. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br. J. Cancer 75 (1997) 650-655
85. Paulsen J.E., Elvsaas I.K., Steffensen I.L., and Alexander J. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis 18 (1997) 1905-1910
86. Boudreau M.D., Sohn K.H., Rhee S.H., Lee S.W., Hunt J.D., and Hwang D.H. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res. 61 (2001) 1386-1391
87. Calviello G., Di Nicuolo F., Gragnoli S., Piccioni E., Serini S., Maggiano N., Tringali G., Navarra P., Ranelletti F.O., and Palozza P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25 (2004) 2303-2310
88. Reddy B.S., and Maruyama H. Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res. 46 (1986) 3367-3370
89. Minoura T., Takata T., Sakaguchi M., Takada H., Yamamura M., Hioki K., and Yamamoto M. Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res. 48 (1988) 4790-4794
90. Takahashi M., Minamoto T., Yamashita N., Kato T., Yazawa K., and Esumi H. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett. 83 (1994) 177-184
91. Takahashi M., Fukutake M., Isoi T., Fukuda K., Sato H., Yazawa K., Sugimura T., and Wakabayashi K. Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 18 (1997) 1337-1342
92. Hendrickse C.W., Keighley M.R., and Neoptolemos J.P. Dietary omega-3 fats reduce proliferation and tumor yields at colorectal anastomosis in rats. Gastroenterology 109 (1995) 431-439
93. Iwamoto S., Senzaki H., Kiyozuka Y., Ogura E., Takada H., Hioki K., and Tsubura A. Effects of fatty acids on liver metastasis of ACL-15 rat colon cancer cells. Nutr. Cancer 31 (1998) 143-150
94. Kontogiannea M., Gupta A., Ntanios F., Graham T., Jones P., and Meterissian S. Omega-3 fatty acids decrease endothelial adhesion of human colorectal carcinoma cells. J .Surg. Res. 92 (2000) 201-205
95. Dwivedi C., Natarajan K., and Matthees D.P. Chemopreventive effects of dietary flaxseed oil on colon tumor development. Nutr. Cancer 51 (2005) 52-58
96. Bommareddy A., Arasada B.L., Mathees D.P., and Dwivedi C. Chemopreventive effects of dietary flaxseed on colon tumor development. Nutr. Cancer 54 (2006) 216-222
97. Williams D., Verghese M., Walker L.T., Boateng J., Shackelford L., and Chawan C.B. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats. Food Chem. Toxicol. 45 (2007) 153-159
98. Petrik M.B., McEntee M.F., Johnson B.T., Obukowicz M.G., and Whelan J. Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J. Nutr. 130 (2000) 2434-2443
99. Newcomer L.M., King I.B., Wicklund K.G., and Stanford J.L. The association of fatty acids with prostate cancer risk. Prostate 47 (2001) 262-268
100. De Stefani E., Deneo-Pellegrini H., Boffetta P., Ronco A., and Mendilaharsu M. Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 335-338
101. Jatoi A., Rowland K., Loprinzi C.L., Sloan J.A., Dakhil S.R., MacDonald N., Gagnon B., Novotny P.J., Mailliard J.A., Bushey T.I., et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J. Clin. Oncol. 22 (2004) 2469-2476
102. Burns C.P., Halabi S., Clamon G., Kaplan E., Hohl R.J., Atkins J.N., Schwartz M.A., Wagner B.A., and Paskett E. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 101 (2004) 370-378
103. Klek S., Kulig J., Szczepanik A.M., Jedrys J., and Kolodziejczyk P. The clinical value of parenteral immunonutrition in surgical patients. Acta Chir. Belg. 105 (2005) 175-179
104. Harle L., Brown T., Laheru D., and Dobs A.S. Omega-3 fatty acids for the treatment of cancer cachexia: issues in designing clinical trials of dietary supplements. J. Altern. Complement Med. 11 (2005) 1039-1046
105. Wigmore S.J., Barber M.D., Ross J.A., Tisdale M.J., and Fearon K.C. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr. Cancer 36 (2000) 177-184
106. Gogos C.A., Ginopoulos P., Salsa B., Apostolidou E., Zoumbos N.C., and Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 82 (1998) 395-402
107. Burns C.P., Halabi S., Clamon G.H., Hars V., Wagner B.A., Hohl R.J., Lester E., Kirshner J.J., Vinciguerra V., and Paskett E. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin. Cancer Res. 5 (1999) 3942-3947
108. Mantovani G., Maccio A., Madeddu C., Gramignano G., Lusso M.R., Serpe R., Massa E., Astara G., and Deiana L. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1030-1034
109. Bruera E., Strasser F., Palmer J.L., Willey J., Calder K., Amyotte G., and Baracos V. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J. Clin. Oncol. 21 (2003) 129-134
110. Fearon K.C., Von Meyenfeldt M.F., Moses A.G., Van Geenen R., Roy A., Gouma D.J., Giacosa A., Van Gossum A., Bauer J., Barber M.D., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52 (2003) 1479-1486
111. Dewey A., Baughan C., Dean T., Higgins B., and Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst. Rev. (2007) CD004597
112. Cerchietti L.C., Navigante A.H., and Castro M.A. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr. Cancer 59 (2007) 14-20
113. Lai V., George J., Richey L., Kim H.J., Cannon T., Shores C., and Couch M. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. Head Neck 30 (2008) 67-74
114. Nakamura K., Kariyazono H., Komokata T., Hamada N., Sakata R., and Yamada K. Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer. Nutrition 21 (2005) 639-649
115. Zheng Y., Li F., Qi B., Luo B., Sun H., Liu S., and Wu X. Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac. J. Clin. Nutr. 16 Suppl. 1 (2007) 253-257
116. Aiko S., Yoshizumi Y., Tsuwano S., Shimanouchi M., Sugiura Y., and Maehara T. The effects of immediate enteral feeding with a formula containing high levels of omega-3 fatty acids in patients after surgery for esophageal cancer. JPEN J. Parenter. Enteral Nutr. 29 (2005) 141-147
117. Heller A.R., Rossel T., Gottschlich B., Tiebel O., Menschikowski M., Litz R.J., Zimmermann T., and Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int. J. Cancer 111 (2004) 611-616
118. Bougnoux P., Hajjaju N., Baucher M.A., Jordan M.L., Goupille C., Body G., and LeFoch O. Docosahexaenoic acid (DHA) intake during first line chemotherapy improves survival in metastatic breast cancer. Proc. Am. Assoc. Cancer Res. 47 (2006) 1237 abstract #5276
119. Giardiello F.M., Hamilton S.R., Krush A.J., Piantadosi S., Hylind L.M., Celano P., Booker S.V., Robinson C.R., and Offerhaus G.J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328 (1993) 1313-1316
120. Jacobs E.J., Rodriguez C., Mondul A.M., Connell C.J., Henley S.J., Calle E.E., and Thun M.J. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J. Natl. Cancer Inst. 97 (2005) 975-980
121. Solomon S.D., McMurray J.J., Pfeffer M.A., Wittes J., Fowler R., Finn P., Anderson W.F., Zauber A., Hawk E., and Bertagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 352 (2005) 1071-1080
122. Bartoli G.M., Palozza P., Marra G., Armelao F., Franceschelli P., Luberto C., Sgarlata E., Piccioni E., and Anti M. n-3 PUFA and alpha-tocopherol control of tumor cell proliferation. Mol. Aspects Med. 14 (1993) 247-252
123. Bartram H.P., Gostner A., Scheppach W., Reddy B.S., Rao C.V., Dusel G., Richter F., Richter A., and Kasper H. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology 105 (1993) 1317-1322
124. Bartram H.P., Gostner A., Reddy B.S., Rao C.V., Scheppach W., Dusel G., Richter A., Richter F., and Kasper H. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio. Eur. J. Cancer Prev. 4 (1995) 231-237
125. Aronson W.J., Glaspy J.A., Reddy S.T., Reese D., Heber D., and Bagga D. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology 58 (2001) 283-288
126. Demark-Wahnefried W., Robertson C.N., Walther P.J., Polascik T.J., Paulson D.F., and Vollmer R.T. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63 (2004) 900-904
127. Rhodes L.E., Shahbakhti H., Azurdia R.M., Moison R.M., Steenwinkel M.J., Homburg M.I., Dean M.P., McArdle F., Beijersbergen van Henegouwen G.M., Epe B., et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis 24 (2003) 919-925